ADAM17 functions as an oncogene and can be a potential therapeutic target in oral cancer, we thus chose it for further study.17, 18 The RT‐PCR and Western blot assay demonstrated that miR‐224 inhibited ADAM17 mRNA and protein expression, respectively (Figure 2B,C). Here, ADAM17 is linked to lip and oral cavity carcinoma.